Trial Profile
A Pilot Study of Outpatient Discharge Therapy With Saxagliptin + Metformin XR or Sulphonylurea for Recently Diagnosed Type 2 Diabetes Presenting With Severe Hyperglycemia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jun 2023
Price :
$35
*
At a glance
- Drugs Saxagliptin/metformin (Primary) ; Glipizide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 22 Jun 2023 Status changed from active, no longer recruiting to completed.
- 04 May 2016 Results published in the Journal of Clinical Endocrinology and Metabolism
- 04 May 2016 Status changed from recruiting to active, no longer recruiting, according to a results published in the Journal of Clinical Endocrinology and Metabolism